Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service Delivery

被引:11
作者
Amoaku, Winfried [1 ]
Bailey, Clare [2 ]
Downey, Louise [3 ]
Gale, Richard P. [4 ]
Ghanchi, Faruque [5 ]
Hamilton, Robin [6 ]
Mahmood, Sajjad [7 ]
Menon, Geeta [8 ]
Nosek, Jenny [9 ]
Pearce, Ian [10 ]
Yang, Yit [11 ]
机构
[1] Univ Nottingham, Acad Ophthalmol, Div Clin Neurosci, Nottingham, England
[2] Univ Hosp Bristol NHS Fdn Trust, Bristol, Avon, England
[3] Hull Univ Teaching Hosp, Hull & East Yorkshire Eye Hosp, Kingston Upon Hull, N Humberside, England
[4] York Teaching Hosp NHS Fdn Trust, York, N Yorkshire, England
[5] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England
[6] Moorfield Eye Hosp NHS Fdn Trust, London, England
[7] Univ Manchester, Manchester Univ NHS Fdn Trust, Manchester Royal Eye Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[8] Frimley Hlth NHS Fdn Trust, Frimley, England
[9] Royal Shrewsbury Hosp, Shrewsbury, Shrops, England
[10] Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool, Merseyside, England
[11] Royal Wolverhampton NHS Trust, Wolverhampton Eye Infirm, Wolverhampton, England
关键词
capacity; intravitreal service; nAMD; resources; MACULAR DEGENERATION; VIRTUAL CLINICS; ANTIBIOTIC-PROPHYLAXIS; RANIBIZUMAB THERAPY; QUALITY-IMPROVEMENT; ENDOPHTHALMITIS; EXTEND; INJECTION; OUTCOMES; BEVACIZUMAB;
D O I
10.2147/OPTH.S233061
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
An aging population leads to increasing demand for medical retina services with chronic diseases being managed in long-term care pathways. Many hospital services struggle to deliver efficient and effective MR care due, at least in part, to infrastructure that does not expand responsively enough to meet the increased demand. A steering committee of retinal specialists from a variety of UK NHS hospital ophthalmology departments with experience of leading and managing NHS retinal services in the intravitreal era came together for the generation of this document to review and compile key aspects that should be considered when optimising intravitreal treatment capacity within MR services. This article aims to provide a useful collation and signposting of key published evidence, consensus and insights on aspects of delivering an intravitreal service, including treatment regimens, virtual clinics, staff training and governance, telemedicine and information technology, and data collection and key performance indicators. The objective is to equip ophthalmologic healthcare professionals with the necessary tools to develop and adapt their local service in the face of current and projected increased demand.
引用
收藏
页码:1315 / 1328
页数:14
相关论文
共 81 条
[51]  
National Health Service (NHS) England, 2014, SURG NEV EV TASKF RE
[52]  
National Institute for Health and Care Excellence (NICE), 2008, RAN PEG TREATM AG RE
[53]  
National Institute for Health and Care Excellence (NICE), 2018, NICE guideline NG82
[54]  
NHS England, 2015, NAT SAF STAND INV PR
[55]  
NICE, 2019, QS180 NICE
[56]   Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting [J].
Pilu, Suman ;
Kotsolis, Athanasios ;
Spaide, Richard F. ;
Slakter, Jason ;
Freund, K. Bailey ;
Sorenson, John ;
Klancnik, James ;
Cooney, Michael .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) :879-882
[57]   Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1 [J].
Regillo, Carl D. ;
Brown, David M. ;
Abraham, Prema ;
Yue, Huibin ;
Ianchulev, Tsontcho ;
Schneider, Susan ;
Shams, Naveed .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (02) :239-248
[58]   The role of OCT-A in retinal disease management [J].
Rodriguez, Francisco J. ;
Staurenghi, Giovanni ;
Gale, Richard .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (11) :2019-2026
[59]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[60]  
Royal Pharmaceutical Society of Great Britain (RPSGB), 2018, SAF SEC HANDL MED TE